[Featured Stock] SK Bioscience, 4th Day After Listing 'Stops Decline and Attempts Rebound'
[Asia Economy Reporter Lee Seon-ae] SK Bioscience is showing an upward trend on the fourth day since its listing.
As of 9:16 AM on the 23rd, SK Bioscience is trading at 146,500 KRW, up 1.74% compared to the previous trading day.
SK Bioscience, which was listed on the 18th, started at 130,000 KRW, double the public offering price of 65,000 KRW, and hit the upper price limit on the first day, achieving the so-called 'ttasang' (double price limit). However, it failed to continue the upper price limit streak afterward. The stock price slipped by -1.48% on the 19th and -13.51% on the 22nd, falling from an intraday high of 190,000 KRW to the 140,000 KRW range.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- Iranian Military Spokesperson: "Ceasefire Was an Opportunity to Strengthen Forces... Ready to Respond to War"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
SK Bioscience is a vaccine specialist company. It is responsible for contract manufacturing (CMO) of representative COVID-19 vaccines AstraZeneca and Novavax, and also handles domestic storage and distribution of Pfizer vaccines.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
